Page last updated: 2024-09-05

lapatinib and Complications, Neoplastic Pregnancy

lapatinib has been researched along with Complications, Neoplastic Pregnancy in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azim, HA; Baselga, J; Campbell, C; de Azambuja, E; Di Cosimo, S; Gelber, RD; Guillaume, S; Hilbers, FS; Huober, J; Ignatiadis, M; Korde, L; Lambertini, M; Martel, S; Moreno-Aspitia, A; Piccart-Gebhart, M; Schuehly, U; Tenglin, RC	1
Broutin, S; Gil, S; Jovelet, C; Mir, O; Paci, A	1
Evens, A; Osborne, CK	1
Boggess, KA; Dees, EC; Dorflinger, LJ; Graham, M; Harris, J; Humes, E; Kelly, H; O'Neil, BH; Spector, NL	1
Berveiller, P; Goffinet, F; Goldwasser, F; Mir, O; Pons, G; Ropert, S; Treluyer, JM	1
Blumenfeld, M; Farrar, W; Landon, MB; Pant, S; Shapiro, CL	1

Reviews

2 review(s) available for lapatinib and Complications, Neoplastic Pregnancy

Article	Year
[Tyrosine kinase inhibitors and pregnancy: A risk to the fetus?]. Bulletin du cancer, 2016, Volume: 103, Issue:5 Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Agents; Dasatinib; Erlotinib Hydrochloride; Female; Fetus; Gefitinib; Humans; Imatinib Mesylate; Lapatinib; Maternal Age; Placenta; Pregnancy; Pregnancy Complications, Neoplastic; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Risk	2016
Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:4 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Lapatinib; Oligohydramnios; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Quinazolines; Receptor, ErbB-2; Taxoids; Trastuzumab; Vinblastine; Vinorelbine	2008

Article

Year

[Tyrosine kinase inhibitors and pregnancy: A risk to the fetus?].

Bulletin du cancer, 2016, Volume: 103, Issue:5

Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Agents; Dasatinib; Erlotinib Hydrochloride; Female; Fetus; Gefitinib; Humans; Imatinib Mesylate; Lapatinib; Maternal Age; Placenta; Pregnancy; Pregnancy Complications, Neoplastic; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Risk

2016

Emerging therapeutic options for breast cancer chemotherapy during pregnancy.

Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:4

Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Lapatinib; Oligohydramnios; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Quinazolines; Receptor, ErbB-2; Taxoids; Trastuzumab; Vinblastine; Vinorelbine

2008

Trials

1 trial(s) available for lapatinib and Complications, Neoplastic Pregnancy

Article	Year
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials. Cancer, 2019, 01-15, Volume: 125, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Humans; Lapatinib; Neoadjuvant Therapy; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Receptor, ErbB-2; Trastuzumab	2019

Article

Year

Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.

Cancer, 2019, 01-15, Volume: 125, Issue:2

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Humans; Lapatinib; Neoadjuvant Therapy; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Receptor, ErbB-2; Trastuzumab

2019

Other Studies

3 other study(ies) available for lapatinib and Complications, Neoplastic Pregnancy

Article	Year
Select interviews from the 2011 San Antonio Breast Cancer Symposium (SABCS) and American Society of Hematology (ASH) Annual Meeting. Oncology (Williston Park, N.Y.), 2011, Volume: 25, Issue:14 Topics: Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fertility Preservation; Humans; Lapatinib; Lymphoma; Molecular Targeted Therapy; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Quinazolines; Receptor, ErbB-2; Rituximab; Trastuzumab; Vinblastine; Vincristine	2011
Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clinical breast cancer, 2006, Volume: 7, Issue:4 Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Infant, Newborn; Lapatinib; Live Birth; Neoplasm Metastasis; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, First; Quinazolines	2006
Treatment of breast cancer with trastuzumab during pregnancy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Mar-20, Volume: 26, Issue:9 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fluorouracil; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lapatinib; Lung Neoplasms; Mastectomy, Modified Radical; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Quinazolines; Trastuzumab	2008